About

Latham BioPharm Group (LBG) unites teams and technologies in the Life Sciences. We provide high level business development, program management, technical, and strategic consulting services and have proven expertise in biodefense and pandemic response, and strategic product development.  We provide these services to life science companies looking to secure, or who have secured, funding in both the federal and commercial sectors.

For over twenty years, we have helped clients identify, evaluate, fund, manage, and monetize opportunities in a wide variety of business segments, generating over $1 billion in government funding and over $100 million in licensing fees and investments.  On the front end, we assist clients in evaluating critical business decisions and connecting with the target markets to assess opportunities with our Strategy and Portfolio Analysis, Market Research, and Commercial and Government Asset Analysis offerings.  We then assist in finding and securing funding through our Business Development and Non-Dilutive Funding Services.   Once funded, we drive successful advancement to a targeted value-inflection point through our Program Management and Product Development Team services.  Finally, we help monetize the results through Business Development and Mergers and Acquisition support.  While all of these services are available a-la-carte, successes un each of often lead to engagement throughout the full life cycle,

The power of this experience should not be underestimated. If you are considering a government contract, or are in need of product development expertise to help progress your program to the next investor milestone, contact us today to explore how Latham BioPharm Group can put the power of our experience to work for you.